世界の降圧薬市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP09812)
◆英語タイトル:Global Antihypertensive Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP09812
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月23日(※2024年版があります。お問い合わせください。)
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、降圧薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。降圧薬の種類別市場規模(利尿薬、アンジオテンシン受容体遮断薬(ARB)、アンジオテンシン変換酵素(ACE)阻害剤、ベータ遮断薬、アルファ遮断薬、カルシウムチャネル遮断薬、レニン阻害薬、血管拡張薬)、用途別市場規模(病院、クリニック、家庭)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Pfizer、Astra Zeneca、Merck、Novartis、Johnson & Johnson、Sanofi、Ranbaxy、Lupin、Boehringer Ingelheim、Daiichi Sankyo
・地域別グローバル市場分析 2015年-2020年
・降圧薬の北米市場(アメリカ、カナダ、メキシコ)
・降圧薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・降圧薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・降圧薬の南米市場(ブラジル、アルゼンチン)
・降圧薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:利尿薬、アンジオテンシン受容体遮断薬(ARB)、アンジオテンシン変換酵素(ACE)阻害剤、ベータ遮断薬、アルファ遮断薬、カルシウムチャネル遮断薬、レニン阻害薬、血管拡張薬
・用途別分析:病院、クリニック、家庭
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Antihypertensive market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.0% in the forecast period of 2020 to 2025 and will expected to reach USD 21480 million by 2025, from USD 19810 million in 2019.

The Antihypertensive market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Antihypertensive market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Antihypertensive market has been segmented into
Diuretics
Angiotensin receptorblockers (ARBs)
Angiotensin converting enzyme (ACE) inhibitors
Beta blockers
Alpha blockers
Calcium channel blockers
Renin inhibitors
Vasodilators

By Application, Antihypertensive has been segmented into:
Hosptial
Clinic
Home

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Antihypertensive market presented in the report. This section sheds light on the sales growth of different regional and country-level Antihypertensive markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Antihypertensive market.

The report offers in-depth assessment of the growth and other aspects of the Antihypertensive market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Antihypertensive Market Share Analysis
Antihypertensive competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Antihypertensive sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Antihypertensive sales, revenue and market share for each player covered in this report.

The major players covered in Antihypertensive are:
Pfizer
Astra Zeneca
Merck
Novartis
Johnson & Johnson
Sanofi
Ranbaxy
Lupin
Boehringer Ingelheim
Daiichi Sankyo

Among other players domestic and global, Antihypertensive market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antihypertensive product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antihypertensive, with price, sales, revenue and global market share of Antihypertensive in 2018 and 2019.
Chapter 3, the Antihypertensive competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antihypertensive breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Antihypertensive market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Antihypertensive sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Antihypertensive Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antihypertensive Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Diuretics
1.2.3 Angiotensin receptorblockers (ARBs)
1.2.4 Angiotensin converting enzyme (ACE) inhibitors
1.2.5 Beta blockers
1.2.6 Alpha blockers
1.2.7 Calcium channel blockers
1.2.8 Renin inhibitors
1.2.9 Vasodilators
1.3 Market Analysis by Application
1.3.1 Overview: Global Antihypertensive Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hosptial
1.3.3 Clinic
1.3.4 Home
1.4 Overview of Global Antihypertensive Market
1.4.1 Global Antihypertensive Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Astra Zeneca
2.2.1 Astra Zeneca Details
2.2.2 Astra Zeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Astra Zeneca SWOT Analysis
2.2.4 Astra Zeneca Product and Services
2.2.5 Astra Zeneca Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson & Johnson SWOT Analysis
2.5.4 Johnson & Johnson Product and Services
2.5.5 Johnson & Johnson Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ranbaxy
2.7.1 Ranbaxy Details
2.7.2 Ranbaxy Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ranbaxy SWOT Analysis
2.7.4 Ranbaxy Product and Services
2.7.5 Ranbaxy Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lupin
2.8.1 Lupin Details
2.8.2 Lupin Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lupin SWOT Analysis
2.8.4 Lupin Product and Services
2.8.5 Lupin Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boehringer Ingelheim SWOT Analysis
2.9.4 Boehringer Ingelheim Product and Services
2.9.5 Boehringer Ingelheim Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Daiichi Sankyo
2.10.1 Daiichi Sankyo Details
2.10.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Daiichi Sankyo SWOT Analysis
2.10.4 Daiichi Sankyo Product and Services
2.10.5 Daiichi Sankyo Antihypertensive Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Antihypertensive Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Antihypertensive Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Antihypertensive Manufacturer Market Share in 2019
3.3.2 Top 6 Antihypertensive Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Antihypertensive Sales, Revenue and Market Share by Regions
4.1.1 Global Antihypertensive Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antihypertensive Revenue and Market Share by Regions (2015-2020)
4.2 North America Antihypertensive Sales and Growth Rate (2015-2020)
4.3 Europe Antihypertensive Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Antihypertensive Sales and Growth Rate (2015-2020)
4.5 South America Antihypertensive Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Antihypertensive Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Antihypertensive Sales, Revenue and Market Share by Country
5.1.1 North America Antihypertensive Sales and Market Share by Country (2015-2020)
5.1.2 North America Antihypertensive Revenue and Market Share by Country (2015-2020)
5.2 United States Antihypertensive Sales and Growth Rate (2015-2020)
5.3 Canada Antihypertensive Sales and Growth Rate (2015-2020)
5.4 Mexico Antihypertensive Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Antihypertensive Sales, Revenue and Market Share by Country
6.1.1 Europe Antihypertensive Sales and Market Share by Country (2015-2020)
6.1.2 Europe Antihypertensive Revenue and Market Share by Country (2015-2020)
6.2 Germany Antihypertensive Sales and Growth Rate (2015-2020)
6.3 UK Antihypertensive Sales and Growth Rate (2015-2020)
6.4 France Antihypertensive Sales and Growth Rate (2015-2020)
6.5 Russia Antihypertensive Sales and Growth Rate (2015-2020)
6.6 Italy Antihypertensive Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Antihypertensive Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Antihypertensive Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Antihypertensive Revenue and Market Share by Regions (2015-2020)
7.2 China Antihypertensive Sales and Growth Rate (2015-2020)
7.3 Japan Antihypertensive Sales and Growth Rate (2015-2020)
7.4 Korea Antihypertensive Sales and Growth Rate (2015-2020)
7.5 India Antihypertensive Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Antihypertensive Sales and Growth Rate (2015-2020)
7.7 Australia Antihypertensive Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Antihypertensive Sales, Revenue and Market Share by Country
8.1.1 South America Antihypertensive Sales and Market Share by Country (2015-2020)
8.1.2 South America Antihypertensive Revenue and Market Share by Country (2015-2020)
8.2 Brazil Antihypertensive Sales and Growth Rate (2015-2020)
8.3 Argentina Antihypertensive Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Antihypertensive Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Antihypertensive Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Antihypertensive Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Antihypertensive Sales and Growth Rate (2015-2020)
9.3 Turkey Antihypertensive Sales and Growth Rate (2015-2020)
9.4 Egypt Antihypertensive Sales and Growth Rate (2015-2020)
9.5 South Africa Antihypertensive Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Antihypertensive Sales and Market Share by Type (2015-2020)
10.2 Global Antihypertensive Revenue and Market Share by Type (2015-2020)
10.3 Global Antihypertensive Price by Type (2015-2020)
11 Global Antihypertensive Market Segment by Application
11.1 Global Antihypertensive Sales Market Share by Application (2015-2020)
11.2 Global Antihypertensive Revenue Market Share by Application (2015-2020)
11.3 Global Antihypertensive Price by Application (2015-2020)
12 Market Forecast
12.1 Global Antihypertensive Sales, Revenue and Growth Rate (2021-2025)
12.2 Antihypertensive Market Forecast by Regions (2021-2025)
12.2.1 North America Antihypertensive Market Forecast (2021-2025)
12.2.2 Europe Antihypertensive Market Forecast (2021-2025)
12.2.3 Asia-Pacific Antihypertensive Market Forecast (2021-2025)
12.2.4 South America Antihypertensive Market Forecast (2021-2025)
12.2.5 Middle East & Africa Antihypertensive Market Forecast (2021-2025)
12.3 Antihypertensive Market Forecast by Type (2021-2025)
12.3.1 Global Antihypertensive Sales Forecast by Type (2021-2025)
12.3.2 Global Antihypertensive Market Share Forecast by Type (2021-2025)
12.4 Antihypertensive Market Forecast by Application (2021-2025)
12.4.1 Global Antihypertensive Sales Forecast by Application (2021-2025)
12.4.2 Global Antihypertensive Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

...

【掲載企業】

Pfizer、Astra Zeneca、Merck、Novartis、Johnson & Johnson、Sanofi、Ranbaxy、Lupin、Boehringer Ingelheim、Daiichi Sankyo

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の降圧薬市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Antihypertensive Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。